Adenocarcinoma of the uterus

Adenocarcinoma of the uterus: causes of development and main treatment methods

Adenocarcinoma of the uterus: causes of development and main treatment methods

Definition of endometrial adenocarcinoma

Endometrial adenocarcinoma is a malignant tumor that originates from the glandular cells of the endometrium, the inner layer of the uterus. This type of uterine cancer is the most common among women and is usually diagnosed in postmenopausal age. Under the microscope, endometrial adenocarcinoma appears as a tumor made up of glandular structures capable of invasive growth into surrounding tissues with the potential for further metastasis.

Risk factors for the development of uterine adenocarcinoma

Risk factors for the development of endometrial adenocarcinoma include prolonged use of hormone replacement therapy, obesity, diabetes, hypertension, and menstrual cycle disorders. In women with disorders of estrogen-progesterone balance and prolonged exposure of estrogens to the endometrium, the risk of developing this tumor may significantly increase. Moreover, hereditary factors also play a role, as women with relatives who have suffered from uterine cancer have a higher likelihood of developing this form of cancer.

  • Long-term use of hormone replacement therapy: Women who have used hormonal medications to treat menopause symptoms have an increased risk of developing endometrial adenocarcinoma.
  • Obesity: Excess weight increases estrogen levels in the body, which contributes to the development of uterine cancer.
  • Diabetes: Abnormal blood glucose levels may increase the likelihood of developing endometrial adenocarcinoma.
  • Hypertension: Consistently high blood pressure may be associated with an increased risk of uterine cancer.
  • Inherited factors: Having cases of uterine cancer in close relatives increases the likelihood of developing this tumor.

Clinical manifestations of uterine adenocarcinoma

Clinical manifestations of endometrial adenocarcinoma may include abnormal bleeding from the genital tract, especially after menopause, as well as unusual vaginal discharge with a blood tinge. Women with this tumor may also experience pain or discomfort in the lower abdomen, bloating, and changes in urination. It is important to note that the symptoms of endometrial adenocarcinoma may be nonspecific and often resemble those of other gynecological conditions, so a specialist consultation is needed for an accurate diagnosis.

  • Abnormal bleeding: Women with endometrial adenocarcinoma often experience unusual bleeding from the genital tract, especially after menopause.
  • Vaginal discharge: Symptoms may include vaginal discharge with blood or other unusual discharges.
  • Pain or discomfort in the lower abdomen: Some women may experience unexplained pain or discomfort in the abdominal area related to endometrial adenocarcinoma.
  • Swelling: An increase in abdominal size or swelling may also be one of the symptoms of uterine cancer.
  • Changes in urination: Women with endometrial adenocarcinoma may experience changes in urination, such as frequent urination or pain during urination.

Effective methods of treating endometrial adenocarcinoma: specialists’ opinions

Experts in the field of oncology emphasize that successful treatment of endometrial adenocarcinoma usually involves a combination of surgery, chemotherapy, and radiation therapy. Surgery, which includes the removal of the uterus and surrounding tissues, remains the primary treatment method for most patients. Experts also point out the importance of a personalized approach to treatment, taking into account the stage and characteristics of the tumor, the overall health of the patient, and their preferences.

Additionally, experts recommend close collaboration between oncologists, surgeons, chemotherapists, and radiologists to develop the optimal treatment plan. It is important to consider the needs of each individual patient and strive to achieve the best possible outcomes with minimal impact on quality of life.

Methods for diagnosing uterine adenocarcinoma

Diagnosis of endometrial adenocarcinoma includes various examination methods for the correct establishment of the diagnosis. One of the main diagnostic methods is histological examination of biopsy material obtained during endometrial biopsy or surgical intervention. Medical educational ultrasound or computed tomography may also be used to visualize changes in the uterus and surrounding tissues.

Additional diagnostic methods may include magnetic resonance imaging, laparoscopy, or other procedures to confirm the stage of the tumor and determine its spread. Accurate and timely diagnosis of endometrial adenocarcinoma plays a crucial role in selecting optimal treatment and prognosis for patients.

  • Histological examination of biopsy material: Conducting endometrial biopsy or surgical intervention to obtain a tissue sample from the uterus for histological analysis.
  • Ultrasound examination (US): The use of ultrasound waves to visualize changes in the structure of the uterus and assess tumor size.
  • Computed tomography (CT): Radiological examination that allows for three-dimensional imaging of internal organs with high detail.
  • Magnetic resonance imaging (MRI): The use of magnetic fields and radio waves to create detailed images of internal organs, aiding in the detection of tumors and their spread.
  • Laparoscopy and loop biopsy: A surgical procedure that involves internal examination of the pelvic organs and, if necessary, the collection of samples for histological analysis.

Methods of treating endometrial adenocarcinoma

Treatment of uterine adenocarcinoma usually involves a combination of surgical methods, chemotherapy, and radiation therapy, developed with consideration of the tumor stage, its spread, and the overall health of the patient. Surgical intervention typically involves the removal of the uterus (hysterectomy) to completely remove the tumor and prevent cancer recurrence. In some cases, the removal of not only the uterus but also the ovaries and tubes may be recommended to prevent the spread of cancer cells.

Chemotherapy and radiation therapy can be used as additional treatment methods to destroy cancer cells and prevent their recurrence. An individual approach to treatment, taking into account the tumor characteristics, the patient’s age, comorbidities, and overall health status, plays an important role in the effectiveness of therapy and prognosis for patients with uterine adenocarcinoma.

  • Surgical intervention: Includes the removal of the uterus (hysterectomy) for the complete and radical removal of the tumor and prevention of cancer recurrence.
  • Chemotherapy: The use of drugs to destroy cancer cells in the body as an additional treatment method after surgery.
  • Radiation therapy: The use of high-energy beams to destroy cancer cells and prevent their growth and spread.
  • Hormonal therapy: The use of hormonal drugs to control the levels of hormones that promote tumor growth, especially in cases where uterine adenocarcinoma is estrogen-dependent.
  • Targeted therapy: The use of drugs aimed at specific molecular targets in cancer cells to prevent their growth and reproduction.

Prevention measures for uterine adenocarcinoma

Prevention of endometrial adenocarcinoma includes a number of measures aimed at reducing the risk of developing this oncological disease. An important aspect of prevention is the regular conduct of gynecological examinations and screening tests, such as cytological research (Pap test) and human papillomavirus (HPV) testing, for the early detection of changes in the tissues of the uterus that may indicate precancerous conditions or cancer.

Improving overall health and maintaining a healthy lifestyle are also crucial in the prevention of endometrial adenocarcinoma. Optimal nutrition, physical activity, quitting smoking and alcohol consumption, as well as maintaining a healthy weight can help reduce the risk of developing uterine cancer and other gynecological diseases.

  • Regular gynecological check-ups: Undergoing regular examinations and screening tests, such as a cytological study (Pap test), for the early detection of changes in uterine tissues.
  • Vaccination against human papillomavirus (HPV): Vaccination can reduce the risk of developing HPV-associated precancerous conditions and cervical cancer, which in turn decreases the likelihood of developing uterine adenocarcinoma.
  • Healthy lifestyle: Maintaining a healthy weight, regular physical exercise, healthy eating, quitting smoking, and limiting alcohol consumption can lower the overall risk of cancer, including uterine adenocarcinoma.
  • Avoiding long-term hormone replacement therapy: Prolonged use of hormonal medications may increase the risk of uterine cancer, therefore, reducing the duration of use or selecting safer treatment options is advisable.
  • Education about risks and symptoms: It is important to inform women about the risks of developing uterine adenocarcinoma, as well as the various symptoms to monitor and discuss with a doctor for early detection and treatment.

Fascinating aspects of uterine adenocarcinoma

Endometrial adenocarcinoma, although a common type of cancer among women, remains the subject of active medical research. Scientists are continuously working to improve the methods of diagnosis, treatment, and prognosis of this oncological disease. One interesting fact is that endometrial adenocarcinoma can have various molecular subtypes, which may influence its behavior, sensitivity to treatment, and prognosis.

Moreover, studies show that the interaction of endometrial adenocarcinoma with surrounding tissues and the cellular microenvironment plays a crucial role in tumor progression and the possibility of recurrence. This underscores the necessity of a personalized approach to the treatment of this cancer, taking into account the molecular and genetic characteristics of the tumor in each patient to achieve the best results.

FAQ